NYSE:BDX - Becton Dickinson and Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $236.43 +1.99 (+0.85 %) (As of 12/10/2018 04:00 PM ET)Previous Close$234.44Today's Range$230.00 - $237.3052-Week Range$209.91 - $265.87Volume893,200 shsAverage Volume1.18 million shsMarket Capitalization$62.89 billionP/E Ratio21.47Dividend Yield1.24%Beta1.2 ProfileDiscussionAnalyst RatingsChartDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. The company's BD Medical segment offers peripheral IV and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, IV fluids, closed-system drug transfer devices, hazardous drug detection, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, sharps disposal systems; infusion pumps and dedicated disposables, medication compounding workflow systems, automated medication dispensing, automated supply management systems, medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes care; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products and systems; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, monoclonal antibodies and kits, reagent systems, bench-side solutions, and molecular indexing and next-generation sequencing sample preparation products, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, thoracic and abdominal drainage, and surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. Becton, Dickinson and Company was founded in 1897 and is based in Franklin Lakes, New Jersey. Receive BDX News and Ratings via Email Sign-up to receive the latest news and ratings for BDX and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry Surgical & medical instruments Sub-IndustryHealth Care Equipment SectorMedical Current SymbolNYSE:BDX Previous Symbol CUSIP07588710 Webwww.bd.com Phone201-847-6800 Debt Debt-to-Equity Ratio0.90 Current Ratio1.03 Quick Ratio0.69 Price-To-Earnings Trailing P/E Ratio21.47 Forward P/E Ratio19.54 P/E Growth1.62 Sales & Book Value Annual Sales$15.98 billion Price / Sales3.97 Cash Flow$18.3849 per share Price / Cash Flow12.86 Book Value$78.25 per share Price / Book3.02 Profitability EPS (Most Recent Fiscal Year)$11.01 Net Income$311 million Net Margins1.47% Return on Equity13.88% Return on Assets5.40% Miscellaneous Employees76,032 Outstanding Shares268,260,000Market Cap$62.89 billion OptionableOptionable Becton Dickinson and (NYSE:BDX) Frequently Asked Questions What is Becton Dickinson and's stock symbol? Becton Dickinson and trades on the New York Stock Exchange (NYSE) under the ticker symbol "BDX." How often does Becton Dickinson and pay dividends? What is the dividend yield for Becton Dickinson and? Becton Dickinson and announced a quarterly dividend on Monday, November 19th. Investors of record on Monday, December 10th will be paid a dividend of $0.77 per share on Monday, December 31st. This represents a $3.08 annualized dividend and a yield of 1.30%. The ex-dividend date of this dividend is Friday, December 7th. This is a boost from Becton Dickinson and's previous quarterly dividend of $0.75. View Becton Dickinson and's Dividend History. How were Becton Dickinson and's earnings last quarter? Becton Dickinson and Co (NYSE:BDX) released its earnings results on Tuesday, November, 6th. The medical instruments supplier reported $2.93 earnings per share for the quarter, meeting analysts' consensus estimates of $2.93. The medical instruments supplier earned $4.40 billion during the quarter, compared to the consensus estimate of $4.36 billion. Becton Dickinson and had a return on equity of 13.88% and a net margin of 1.47%. The firm's revenue for the quarter was up 39.0% on a year-over-year basis. During the same period last year, the business posted $2.40 EPS. View Becton Dickinson and's Earnings History. When is Becton Dickinson and's next earnings date? Becton Dickinson and is scheduled to release their next quarterly earnings announcement on Tuesday, February 5th 2019. View Earnings Estimates for Becton Dickinson and. What guidance has Becton Dickinson and issued on next quarter's earnings? Becton Dickinson and issued an update on its FY19 earnings guidance on Tuesday, November, 6th. The company provided EPS guidance of $12.05 to $12.15 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $12.62. The company issued revenue guidance of $17.34 billion to $17.50 billion, compared to the consensus revenue estimate of $17.70 billion.Becton Dickinson and also updated its FY 2019 guidance to $12.05-12.15 EPS. What price target have analysts set for BDX? 14 brokerages have issued 12-month price targets for Becton Dickinson and's stock. Their predictions range from $175.00 to $280.00. On average, they anticipate Becton Dickinson and's stock price to reach $255.2857 in the next year. This suggests a possible upside of 8.0% from the stock's current price. View Analyst Price Targets for Becton Dickinson and. What is the consensus analysts' recommendation for Becton Dickinson and? 14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Becton Dickinson and in the last year. There are currently 5 hold ratings and 9 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Becton Dickinson and. Has Becton Dickinson and been receiving favorable news coverage? News headlines about BDX stock have trended very positive on Monday, according to InfoTrie. The research firm identifies negative and positive news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Becton Dickinson and earned a media sentiment score of 3.9 on InfoTrie's scale. They also gave press coverage about the medical instruments supplier a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the stock's share price in the next several days. Who are some of Becton Dickinson and's key competitors? Some companies that are related to Becton Dickinson and include 3M (MMM), Stryker (SYK), Boston Scientific (BSX), Baxter International (BAX), FRESENIUS SE &/S (FSNUY), ResMed (RMD), ABIOMED (ABMD), Teleflex (TFX), DexCom (DXCM), Hill-Rom (HRC), Haemonetics (HAE), Insulet (PODD), ICU Medical (ICUI), Penumbra (PEN) and Globus Medical (GMED). Who are Becton Dickinson and's key executives? Becton Dickinson and's management team includes the folowing people: Mr. Vincent A. Forlenza, Chairman & CEO (Age 65)Mr. Thomas E. Polen Jr., Pres & COO (Age 45)Mr. Christopher R. Reidy, Exec. VP, CFO & Chief Admin. Officer (Age 61)Mr. Alexandre Conroy, Pres of Worldwide Medication & Procedural Solutions (Age 55)Mr. Charles R. Bodner, Sr. VP of Corp. Fin. & Chief Accounting Officer (Age 47) Who are Becton Dickinson and's major shareholders? Becton Dickinson and's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (8.10%), BlackRock Inc. (7.11%), FMR LLC (6.49%), JPMorgan Chase & Co. (1.73%), Franklin Resources Inc. (1.39%) and Wells Fargo & Company MN (1.33%). Company insiders that own Becton Dickinson and stock include Alexandre Conroy, Charles R Bodner, David F Melcher, Ellen R Strahlman, Gary M Cohen, James C Lim, James W Borzi, Jeffrey S Sherman, John E Gallagher, Linda M Tharby, Nabil Shabshab, Ribo Alberto Mas, Stephen Sichak, Thomas E Polen Jr, Timothy M Ring and Vincent A Forlenza. View Institutional Ownership Trends for Becton Dickinson and. Which major investors are selling Becton Dickinson and stock? BDX stock was sold by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., The Manufacturers Life Insurance Company , Mitsubishi UFJ Trust & Banking Corp, Sirios Capital Management L P, Bank of New York Mellon Corp, Deutsche Bank AG, Nuance Investments LLC and Putnam Investments LLC. Company insiders that have sold Becton Dickinson and company stock in the last year include Alexandre Conroy, Charles R Bodner, James C Lim, James W Borzi, John E Gallagher, Nabil Shabshab, Ribo Alberto Mas, Thomas E Polen Jr, Timothy M Ring and Vincent A Forlenza. View Insider Buying and Selling for Becton Dickinson and. Which major investors are buying Becton Dickinson and stock? BDX stock was acquired by a variety of institutional investors in the last quarter, including Morgan Stanley, FMR LLC, Cornerstone Wealth Management LLC, Vanguard Group Inc., BlackRock Inc., Thrivent Financial for Lutherans, Marshall Wace North America L.P. and Comgest Global Investors S.A.S.. View Insider Buying and Selling for Becton Dickinson and. How do I buy shares of Becton Dickinson and? Shares of BDX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Becton Dickinson and's stock price today? One share of BDX stock can currently be purchased for approximately $236.43. How big of a company is Becton Dickinson and? Becton Dickinson and has a market capitalization of $62.89 billion and generates $15.98 billion in revenue each year. The medical instruments supplier earns $311 million in net income (profit) each year or $11.01 on an earnings per share basis. Becton Dickinson and employs 76,032 workers across the globe. What is Becton Dickinson and's official website? The official website for Becton Dickinson and is http://www.bd.com. How can I contact Becton Dickinson and? Becton Dickinson and's mailing address is ONE BECTON DR, FRANKLIN LAKES NJ, 07417. The medical instruments supplier can be reached via phone at 201-847-6800. MarketBeat Community Rating for Becton Dickinson and (NYSE BDX)Community Ranking: 2.3 out of 5 ( )Outperform Votes: 425 (Vote Outperform)Underperform Votes: 504 (Vote Underperform)Total Votes: 929MarketBeat's community ratings are surveys of what our community members think about Becton Dickinson and and other stocks. Vote "Outperform" if you believe BDX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BDX will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 12/10/2018 by MarketBeat.com StaffFeatured Article: What are municipal bonds?